The -308 (G/A) single nucleotide polymorphism in the TNF-α gene and the risk of major depression in the elderly

International Journal of Geriatric Psychiatry

Volumn 25, Issue 3, 2010, Pages 219-223

  Cerri, Anna Paola ^a   Arosio, Beatrice ^b   Viazzoli, Chiara ^b   Confalonieri, Roberto ^a   Vergani, Carlo ^b   Annoni, Giorgio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Gene polymorphisms; Inflammation; Major depression; TNF

Indexed keywords

ALANINE; GLYCINE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERIATRIC DEPRESSION SCALE; GERIATRICS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649086050     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2323     Document Type: Article

References (31)

1. Abraham LJ, Kroeger KM. 1999. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66(4): 562-566.
2. Anisman H, Merali Z, Hayley S. 2008. Neurotrasmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85(1): 1-74.
3. Anisman H, Ravindran AV, Griffiths J, Merali Z. 1999. Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46: 1649-1655.
4. Arosio B, Trabattoni D, Galimberti L, et al. 2004. Interleukin-10 and interelukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25(8): 1009-1015.
5. Basterzi AD, Aydemir C, Kisa C, et al. 2005. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 20: 473-476.
6. Cockrell JR, Folstein MF. 1988. Mini-mental state examination (MMSE). Psychopharmacol Bull 24: 689-692.
7. Danner M, Kasl SV, Abramson JL, Vaccarino V. 2003. Association between depression and elevated C-reactive protein. Psychosom Med 65: 347-356.
8. Dantzer R, Wolman E, Vitkovic L, Yirmiya R. 1999. Cytokines and depression: fortuitous or causative association? Mol Psychiatry 4: 328-332.
9. Galinanes M, James M, Codd V, Baxi A, Hadjinikolaou L. 2008. TNF-a gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment. Eur J Cardiothorac Surg 34(2): 332-337.
10. Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P. 2003. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 19(4): 183-188.
11. Himmerich H, Binder EB, Künzel HE, et al. 2006. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 60(8): 882-888.
12. Jun TY, Pae CU, Han H, et al. 2003. Possible association between -G308A tumour necrosis factor-α gene polymorphism and major depressive disorder in the Korean population. Psychiatry Genet 13: 179-181.
13. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacolgy 22: 370-379.
14. Levine J, Barak Y, Chengappa KN, et al. 2000. Cerebrospinal cytokine levels in patients with acute depression. Neuropsycobiology 40(4): 171-176.
15. Lio D, Annoni G, Licastro F, et al. 2006. Tumor necrosis factor-α -308 A/G polymorphism is associated with age at onset of Alzehimer's disease. Mech Ageing Dev 127: 567-571.
16. Maes M. 1999. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461: 25-45.
17. Maletic V, Robinson M, Oakes T, et al. 2007. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract 61: 2030-2040.
18. Marotte H, Arnaud B, Diasparra J, Zrioual S, Miossec P. 2008. Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor a gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor αinhibitor. Arthritis Rheum 58: 1258-1263.
19. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3): 1215.
20. Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA. 2001. Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. GenesImmun 2: 280-2283.
21. Raison CL, Capuron L, Miller AH. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. TrendsImmunol 27: 26-27.
22. Schiepers OJG, Wichers MC, Maes M. 2005. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201-217.
23. Sluzewska A, Rybakowski JK, Laciak M, et al. 1995. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762: 474-476.
24. Song C, Dinan TG, Leonard BE. 1994. Changes in immunoglobulins, complement and acute phase proteins in depressed patients and normal controls. J Affect Disord 30(4): 283-288.
25. Taudorf S, Krabbe KS, Berg RM, et al. 2008. Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans. Clin Exp Immunol 152(1): 147-152.
26. Thomas AJ, Davis S, Morris C, et al. 2005. Increase in IL-1-β in late life depression. Am J Psychiatry 162(1): 175-177.
27. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. 2003. Increased serum TNF-α levels and treatment response in major depressive disorders. Psychopharmacology (Berl) 170: 429-433.
28. Wilson AG, Symons JA, McDowell TL, Mcdevitt HO, Duff GW. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94(7): 3195-3199.
29. Wright SL, Persad C. 2007. Distinguishing between depression and dementia in older persons: neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol 20(4): 189-198.
30. Yesavage JA, Brink TL, Rose TL, et al. 1983. Development and validation of a geriatric screening scale: a preliminary report. J Psychiatry Res 17: 37-49.
31. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ. 2003. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 28(6): 1182-1185.